223. Primary membranoproliferative glomerulonephritis
18 clinical trials,   14 drugs   (DrugBank: 7 drugs),   7 drug target genes,   14 drug target pathways

Searched query = "Primary membranoproliferative glomerulonephritis", "Dense deposit disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02302755
(ClinicalTrials.gov)
November 20145/11/2014TP10 Use in Patients With C3 Glomerulopathy (C3G)A Pilot, Open-Label Single Center Trial of TP10 in Pediatric and Adult Patients With C3 Glomerulopathy (C3G)Dense Deposit DiseaseDrug: TP10University of IowaNULLWithdrawn4 YearsN/ABoth0Phase 1United States